These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31798348)

  • 1. Melatonin: an anti-tumor agent for osteosarcoma.
    Fathizadeh H; Mirzaei H; Asemi Z
    Cancer Cell Int; 2019; 19():319. PubMed ID: 31798348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.
    Lu KH; Lin RC; Yang JS; Yang WE; Reiter RJ; Yang SF
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin in osteosarcoma: an effective drug?
    Panzer A
    Med Hypotheses; 1997 Jun; 48(6):523-5. PubMed ID: 9247897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.
    Al-Ansari N; Samuel SM; Büsselberg D
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Kleinerman ES
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteosarcoma: review of the past, impact on the future. The American experience.
    Jaffe N
    Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin: A new inhibitor agent for cervical cancer treatment.
    Shafabakhsh R; Reiter RJ; Mirzaei H; Teymoordash SN; Asemi Z
    J Cell Physiol; 2019 Dec; 234(12):21670-21682. PubMed ID: 31131897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin is an appropriate candidate for breast cancer treatment: Based on known molecular mechanisms.
    Amin N; Shafabakhsh R; Reiter RJ; Asemi Z
    J Cell Biochem; 2019 Aug; 120(8):12208-12215. PubMed ID: 31041825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway.
    Lu KH; Su SC; Lin CW; Hsieh YH; Lin YC; Chien MH; Reiter RJ; Yang SF
    J Pineal Res; 2018 Oct; 65(3):e12507. PubMed ID: 29766567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.
    Cheng Y; Cai L; Jiang P; Wang J; Gao C; Feng H; Wang C; Pan H; Yang Y
    Eur J Pharmacol; 2013 Sep; 715(1-3):219-29. PubMed ID: 23726949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is known about melatonin, chemotherapy and altered gene expression in breast cancer.
    Martínez-Campa C; Menéndez-Menéndez J; Alonso-González C; González A; Álvarez-García V; Cos S
    Oncol Lett; 2017 Apr; 13(4):2003-2014. PubMed ID: 28454355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling.
    Qu H; Xue Y; Lian W; Wang C; He J; Fu Q; Zhong L; Lin N; Lai L; Ye Z; Wang Q
    Life Sci; 2018 Aug; 207():253-264. PubMed ID: 29689273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers.
    Menéndez-Menéndez J; Martínez-Campa C
    Int J Endocrinol; 2018; 2018():3271948. PubMed ID: 30386380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin regulates tumor angiogenesis via miR-424-5p/VEGFA signaling pathway in osteosarcoma.
    Vimalraj S; Saravanan S; Raghunandhakumar S; Anuradha D
    Life Sci; 2020 Sep; 256():118011. PubMed ID: 32592723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy.
    Xu C; Wang M; Guo W; Sun W; Liu Y
    Front Oncol; 2021; 11():672490. PubMed ID: 34094974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence.
    Lu KH; Lin CW; Hsieh YH; Su SC; Reiter RJ; Yang SF
    Cancer Metastasis Rev; 2020 Mar; 39(1):303-320. PubMed ID: 32086631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Melatonin in the Inflammatory Process and its Therapeutic Potential.
    Carrascal L; Nunez-Abades P; Ayala A; Cano M
    Curr Pharm Des; 2018; 24(14):1563-1588. PubMed ID: 29701146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin, immune modulation and aging.
    Zhang Z; Inserra PF; Liang B; Ardestani SK; Elliott KK; Molitor M; Watson RR
    Autoimmunity; 1997; 26(1):43-53. PubMed ID: 9556354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapeutic strategies and novel approaches in osteosarcoma.
    Ando K; Heymann MF; Stresing V; Mori K; Rédini F; Heymann D
    Cancers (Basel); 2013 May; 5(2):591-616. PubMed ID: 24216993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.